Quaggin Susan E 4

What Happened Susan E. Quaggin, a director of AbbVie Inc. (ABBV), received an award of 62 shares (derivative stock-equivalent units) on 2026-06-30. The units were valued at $251.64 each, for a total reported value of $15,602. This was an award/grant (transaction code A) of derivative units rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-30; Filing date: 2026-07-02 (filed within the Form 4 reporting window).
• Quantity/price/value: 62 shares × $251.64 = $15,602 (derivative stock-equivalent units).
• Type: Award/Grant (derivative stock-equivalent units), not a cash purchase or sale.
• Shares owned after transaction: Not specified in the provided excerpt.
• Footnotes: F1 — Director fees are credited to an unfunded book account and distributed over a period tied to board service (generally commencing at age 65 or upon retirement); units track AbbVie stock returns. F2 — Balance includes units acquired via dividend reinvestment.

Context This is a routine director compensation award (stock-equivalent units held in an unfunded account) rather than an insider buying or selling shares on the open market. Such awards are commonly used to compensate directors over time and do not by themselves indicate a change in the director’s market sentiment.